Orikines’s Website
Barcelona, ES · Founded 2022 · 18 employees on LinkedIn · 2 known investors
Orikine Bio develops precision-engineered bi-specific cytokine therapies ("Foldikines") that reprogram immune signaling to treat severe autoimmune and inflammatory diseases. It is a biotechnology company operating a proprietary cytokine engineering platform.
Founders & leadership
Board
LE
Larry EdwardsChairman of the Board
Investors · 2
Frequently asked questions
- What does Orikines’s Website do?
- Orikine Bio develops precision-engineered bi-specific cytokine therapies ("Foldikines") that reprogram immune signaling to treat severe autoimmune and inflammatory diseases. It is a biotechnology company operating a proprietary cytokine engineering platform.
- Who are Orikines’s Website's investors?
- Orikines’s Website's investors include AdBio partners, Asabys Partners.
- Where is Orikines’s Website headquartered?
- Orikines’s Website is headquartered in Barcelona, ES.